Great Elm grows PAP supply business
By HME News Staff
Updated Wed February 12, 2020
WALTHAM, Mass. - Great Elm Capital Group's DME operating companies generated adjusted EBITDA of $3.5 million for the three months ended Dec. 31, 2019. Management expects continued growth in fiscal year 2020, supported by key performance indicators, including about 8.8% quarter-over-quarter growth in PAP supply orders. The company continues to pursue M&A opportunities with complementary product profiles to increase market penetration and extend existing geographic markets. It says it has identified “a large number of potential acquisition targets with strong product fit.” Great Elm also operates in investment management and real estate verticals.
Comments